References
- World Health Organization. Cancer pain relief and palliative care: a report of a WHO expert committee. WHO Technical Report Series 1990:804
- Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. J Am Med Assoc 1995;274:1870–3
- Southam MA. Transdermal fentanyl therapy: system design, pharmacokietics and efficacy. Anticancer Drugs 1995;6 (Suppl 3):29–34
- Hammack JE, Mailliard JA, Loprinzi CL, Rospond RM, O’Fallon JR, Wilweding MB, et al. Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage 1996;12:234–40
- Korte W, de Stoutz N, Morant R. Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients. J Pain Symptom Manage 1996;11:139–46
- Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP. Transdermal fentanyl in opioid-naïve cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naïve patients and a group using codeine. J Pain Symptom Manage 2000;19:185–92
- Grond S, Zech D, Lehmann KA, Radbruch L, Breitenbach H, Hertel D. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997;69:191–8
- Zech DF, Grond S, Lynch J, Dauer HG, Stollenwerk B, Lehmann KA. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. Pain 1992;50:293–301
- Ahmedzai S, Allan E, Fallon M, Finlay IG, Hanks GW, Hanna M, et al. Transdermal fentanyl in cancer pain. J Drug Dev 1994;6:93–7
- Donner B, Zenz M, Strumpf M, Raber M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996;64:527–34
- Sloan PA, Moulin DE, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998;16:102–11
- Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definition of terms. Seattle: IASP Press; 1994
- Chandler S, Payne R. Economics of unrelieved cancer pain. Am J Hosp Palliat Care 1998;15:223–6
- Slappendel R, Lako SJ, Crul BJP. Gastrointestinal adverse events diminishes after switch over from morphine to transdermal fentanyl. Ann Oncol 1994;5\(Suppl 8):S200 [abstract]
- Yeo W, Lam KK, Chan AT, Leug TW, Nip SY, Johnson PJ. Transdermal fentanyl for severe cancer-related pain. Palliat Med 1997;11:233–9
- Tooley PJH, Cookson RF, Jones M, Nuyts GD. Medical events and resource utilisation in cancer-pain patients treated with strong opioids: an analysis of the UK General Practice Research Database. J Outcomes Res 2000;4:1–14
- Maves TJ, Barcellos WA. Management of cancer pain with transdermal fentanyl: phase IV trial. J Pain Symptom Manage 1992;7(Suppl 3):S58–S62